Abstract:Historically, cardiovascular prevention has been predominantly focused on stress-induced ischemia, but recent trials have challenged this paradigm, highlighting the emerging role of vulnerable, non-flow-limiting coronary plaques, leading to a shift towards integrating plaque morphology with functional data into risk prediction models. Coronary computed tomography angiography (CCTA) represents a high-resolution, low-risk, and largely available non-invasive modality for the precise delineation of plaque composition, morphology, and inflammatory activity, further enhancing our ability to stratify high-risk plaque and predict adverse cardiovascular outcomes. Coronary artery calcium (CAC) scoring, derived from CCTA, has emerged as a promising tool for predicting future cardiovascular events in asymptomatic individuals, demonstrating incremental prognostic value beyond traditional cardiovascular risk factors in terms of myocardial infarction, stroke, and all-cause mortality. Additionally, CCTA-derived information on adverse plaque characteristics, geometric characteristics, and hemodynamic forces provides valuable insights into plaque vulnerability and seems promising in guiding revascularization strategies. Additionally, non-invasive assessments of epicardial and pericoronary adipose tissue (PCAT) further refine risk stratification, adding prognostic significance to coronary artery disease (CAD), correlating with plaque development, vulnerability, and rupture. Moreover, CT imaging not only aids in risk stratification but is now emerging as a screening tool able to monitor CAD progression and treatment efficacy over time. Thus, the integration of CAC scoring and PCAT evaluation into risk stratification algorithms, as well as the identification of high-risk plaque morphology and adverse geometric and hemodynamic characteristics, holds promising results for guiding personalized preventive interventions, helping physicians in identifying high-risk individuals earlier, tailoring lifestyle and pharmacological interventions, and improving clinical outcomes in their patients.

Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease

Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis

Invasive or non-invasive imaging for detecting high-risk coronary lesions?

Intravascular imaging of vulnerable coronary plaque: current and future concepts

Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque

Novel imaging modalities for the identification of vulnerable plaques

Noninvasive detection of coronary artery disease: challenges for prevention of disease and clinical events

Nanotechnology and atherosclerosis imaging: emerging diagnostic and therapeutic applications

Multimodal intravascular imaging technology for characterization of atherosclerosis

Coronary Artery Plaque Imaging

What Will Noninvasive Carotid Atherosclerosis Imaging Show Us about High-Risk Coronary Plaques?

Invasive coronary imaging of inflammation to further characterize high-risk lesions: what options do we have?

Atherosclerosis imaging on the molecular level

Beyond Stress Ischemia: Unveiling the Multifaceted Nature of Coronary Vulnerable Plaques Using Cardiac Computed Tomography

Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology

Biomechanical stress in coronary atherosclerosis: emerging insights from computational modelling

Enhancing cardiovascular risk stratification: Radiomics of coronary plaque and perivascular adipose tissue - Current insights and future perspectives

Seeing is believing: pathway strategies for a personalised non-invasive diagnosis of coronary artery disease

Emerging Hybrid Intracoronary Imaging Technologies and Their Applications in Clinical Practice and Research

Novel theranostic approaches to neovascularized atherosclerotic plaques

Multi-Modality Imaging of Atheromatous Plaques in Peripheral Arterial Disease: Integrating Molecular and Imaging Markers